A Trial Evaluating the Efficacy and Safety of HLD200 in Children With ADHD

NCT02255513 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

43

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Hyperactivity Disorder

Interventions

DRUG: HLD200
DRUG: Placebo

Sponsor

Ironshore Pharmaceuticals and Development, Inc